| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |